"Beaumont Hospital, Dearborn has proudly served residents across southeastern Michigan since 1953. It became part of Beaumont Health in September 2014. Beaumont, Dearborn is a major teaching and research hospital and home to three medical residency programs in partnership with the Wayne State University School of Medicine. Beaumont, Dearborn is verified as a Level 2 trauma center and has been recognized for clinical excellence and innovation in the fields of orthopedics, neurosciences (Stroke Center of Excellence), women’s health, heart and vascular and cancer care."

During the past decade, Beaumont Hospital - Dearborn conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 252 clinical trials were completed, i.e. on average, 262.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 86 clinical trials were completed. i.e. 390.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beaumont Hospital - Dearborn" #1 sponsor was "National Cancer Institute (NCI)" with 140 trials, followed by "Alliance for Clinical Trials in Oncology" with 92 trials sponsored, "SWOG Cancer Research Network" with 64 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Eastern Cooperative Oncology Group" with 17 trials sponsored. Other sponsors include 76 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beaumont Hospital - Dearborn" #1 collaborator was "National Cancer Institute (NCI)" with 244 trials as a collaborator, "NRG Oncology" with 43 trials as a collaborator, "SWOG Cancer Research Network" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "Eastern Cooperative Oncology Group" with 11 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Beaumont Hospital - Dearborn" are "Breast Cancer" (43 trials), "Lung Cancer" (29 trials), "Lymphoma" (14 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials) and "Prostate Cancer" (13 trials). Many other conditions were trialed in "Beaumont Hospital - Dearborn" in a lesser frequency.

Most popular intervention types in "Beaumont Hospital - Dearborn" are "Drug" (312 trials), "Other" (212 trials), "Biological" (128 trials), "Radiation" (71 trials) and "Procedure" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (99 trials), "Quality-of-Life Assessment" (61 trials), "placebo" (36 trials), "Paclitaxel" (34 trials) and "Questionnaire Administration" (34 trials). Other intervention names were less common.

The vast majority of trials in "Beaumont Hospital - Dearborn" are 308 trials for "All" genders, 82 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "Beaumont Hospital - Dearborn". undefined are not yet recruiting, 26 are recruiting, 114 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 228 completed trials in Beaumont Hospital - Dearborn, 1 suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Beaumont Hospital - Dearborn, 15 "Phase 1" clinical trials were conducted, 193 "Phase 2" clinical trials and 184 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 17 trials that are defined as “Not Applicable".